Can high SHBG lower free testosterone even when total levels look less abnormal?

For a 51-year-old female, evaluating androgen status requires looking beyond total hormone levels. Sex Hormone-Binding Globulin (SHBG) serves as a primary regulator of testosterone bioavailability, and its elevation can mask underlying hormone deficiencies.

Mechanistic pathway

• High-affinity binding: SHBG binds testosterone with remarkable affinity, characterized by association constants of approximately $5.97 \times 10^8$ to $1.0 \times 10^9$ L/mol. In normal physiological states, 65% to 80% of circulating testosterone is bound, leaving only 1% to 2% free.
• Equilibrium shifts: According to mass-action equilibrium dynamics, an increase in SHBG concentration expands the total binding capacity. This drives a larger fraction of circulating testosterone into a bound state, lowering the concentration of unbound, biologically active free testosterone even when total testosterone levels remain stable.
• Hepatic stimulation: Elevating factors include oral estrogen therapy and hyperthyroidism, both of which directly stimulate the liver to increase SHBG synthesis.

Clinical implications

• Masked deficiency: This shift can mask functional androgen deficiency. Patients may experience clinical symptoms of low testosterone—specifically hypoactive sexual desire disorder (HSDD) and low libido—while total testosterone measurements fall within normal reference ranges.
• Diagnostic precision: Under conditions of elevated SHBG, relying on total testosterone can lead to misdiagnosis. Accurate assessment of bioavailable hormone levels requires direct measurement via equilibrium dialysis or calculation of the Free Androgen Index (FAI).

Bottom line

• Bottom line: Elevated SHBG reduces bioavailable free testosterone through high-affinity binding, which can cause functional androgen deficiency and low libido even when total hormone levels appear normal.